Broncus Holding Corp
Company Profile
Business description
Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD.
Contact
No. 88 Jiangling Road, Xixing Street
Room 801, 8th Floor, Building 8
Binjiang District
Hangzhou
CHNT: +86 57186595016
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
208
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,571.40 | 40.30 | -0.47% |
CAC 40 | 7,831.99 | 78.50 | -0.99% |
DAX 40 | 23,909.38 | 213.02 | -0.88% |
Dow JONES (US) | 41,860.44 | 816.80 | -1.91% |
FTSE 100 | 8,722.85 | 63.61 | -0.72% |
HKSE | 23,544.31 | 283.47 | -1.19% |
NASDAQ | 18,872.64 | 270.07 | -1.41% |
Nikkei 225 | 36,985.87 | 313.11 | -0.84% |
NZX 50 Index | 12,662.25 | 40.85 | -0.32% |
S&P 500 | 5,844.61 | 95.85 | -1.61% |
S&P/ASX 200 | 8,348.70 | 38.10 | -0.45% |
SSE Composite Index | 3,380.19 | 7.39 | -0.22% |